<DOC>
	<DOCNO>NCT01211145</DOCNO>
	<brief_summary>The purpose study investigate ZomigÂ® Nasal Spray help child ( age 12-17 year ) migraine headache feel well . This do compare 3 different dos Zomig Nasal Spray placebo nasal spray ( inactive treatment ) .</brief_summary>
	<brief_title>Zomig - Treatment Acute Migraine Headache Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Zolmitriptan</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<criteria>Provision write informed consent parent legal guardian , write assent provide patient prior study specific procedure . Established diagnosis migraine . History minimum 2 migraine attack ( moderately severely disable ) per month . Any medical condition may put patient increase risk exposure zolmitriptan may interfere safety efficacy assessment . A history basilar , ophthalmoplegic , hemiplegic migraine headache potentially serious neurological condition associate headache . Have unacceptable adverse experience follow previous use 5HT1B/1D agonist drug .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Headache</keyword>
	<keyword>Pain</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Adolescents</keyword>
</DOC>